Sign in to view this subscriber-only content

To access premium content, please take a minute to log into your subscribed account or sign up for a new subscription.

Current subscribers: Sign in New/registered users: Subscribe for access

Subscribers also enjoy unlimited access to other premium content


PCAOB issues new guidance on auditing estimates


The PCAOB has issued new guidance to auditors about how to comply with new rules on auditing estimates, supervising specialists, and relying on their work.

United Kingdom

Amid industry crackdown, U.K. audit firms evolving with the times


It’s been an intense year for the audit industry in the United Kingdom—and things are expected only to get tougher as a new audit regulator, with new leadership and stronger statutory powers, prepares to take the reins.


Deutsche Bank to pay $16M in FCPA case over hiring practices


Deutsche Bank has become the latest financial institution to pay a penalty for violations of the Foreign Corrupt Practices Act over questionable hiring practices, showcasing a litany of compliance failures.


FASB plans delay for new insurance standard


FASB is proposing another accounting delay, this time for a standard that will change the way companies recognize long-term insurance obligations.


Is whistleblowing working? New claims raise questions


Sweeping, open allegations of fraud against major public companies raise fresh questions about the effectiveness of regulatory whistleblower programs.

American Airlines

American Airlines to pay $22.1M over falsified mail delivery allegations


American Airlines has agreed to pay $22.1 million to resolve allegations of violations of the False Claims Act regarding the reporting of international delivery times.


TherapeuticsMD to pay $200K for Reg FD violations


Pharmaceutical company TherapeuticsMD agreed to pay a $200,000 penalty to resolve charges brought by the SEC for Reg FD violations. The case imparts some compliance lessons.


DOJ closes FCPA probe into Misonix


The DOJ has now closed its investigation into medical device company Misonix—about a month after the SEC closed its probe—without bringing enforcement actions. The FCPA investigation still resulted in some extensive anti-corruption compliance reforms.